Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Esketamine for Analgesia in Septic Shock
NCT05839366Phase 3Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- May 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of esketamine in septic shock, sponsored by Nanfang Hospital, Southern Medical University. Status: unknown.
02
Drugs
esketamine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT05839366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05839366.